Study of ARO-DUX4 in Adult Patients With Facioscapulohumeral Muscular Dystrophy Type 1

Conditions: Facio-Scapulo-Humeral Dystrophy Interventions: Drug: ARO-DUX4 for Injection; Drug: Placebo Sponsors: Arrowhead Pharmaceuticals Not yet recruiting

https://clinicaltrials.gov/study/NCT06131983

Source: ClinicalTrials.gov - November 15, 2023 Category: Research Source Type: clinical trials

More News: Facioscapulohumeral Muscular Dystrophy (FSHD) | Muscular Dystrophy | Reflex Sympathetic Dystrophy | Research | Study